The Marqués de Valdecilla Research Institute (IDIVAL) has participated in the second annual meeting of the European project Halt‑RONIN, held at the Faculty of Pharmacy of the University of Lisbon (Portugal). The event brought together the partners of the international consortium to review the scientific progress achieved during the project’s first year and to coordinate […]
The Marqués de Valdecilla Research Institute (IDIVAL) took part in the Kick‑off Meeting of the European project Halt‑RONIN, held at the Royal University College María Cristina in San Lorenzo de El Escorial (Madrid) and coordinated by the Complutense University of Madrid (UCM). This meeting brought together the international partners of the consortium with the aim […]
The Marqués de Valdecilla Research Institute (IDIVAL) has organized, together with Mutua Montañesa, an awareness day on occupational risk prevention based on the use of virtual reality—an innovative technology that allows participants to experience risk situations in safe and immersive environments. During the activity, participants used virtual reality headsets to practice a cardiopulmonary resuscitation (CPR) […]
Collaboration between engineers, physicians and nursing staff has made it possible to create personalized devices that reduce children’s anxiety during chemotherapy and improve their well‑being and safety. Innovation can emerge from everyday needs identified by healthcare professionals themselves. The partnership between the Prototyping Unit of IDIVAL’s Innovation Area and the Hematology and Advanced Therapies team […]
The IDIVAL Nursing Group analyzes the effects of the intervention in civic centers and primary schools The Nursing Group of the Marqués de Valdecilla Research Institute (IDIVAL) has evaluated the impact of the workshop “Being born, dying, loving, caring”, an intervention delivered by midwives and aimed at children aged 6 to 12, implemented in two […]
The training, which will take place from 9 to 18 November in virtual format, will equip biosanitary professionals with the international standards governing clinical trials The Marqués de Valdecilla Research Institute (IDIVAL) will hold the seventh edition of the Good Clinical Practice ICH E6 (R3) Course from 9 to 18 November 2026, a training initiative […]
The study, published in the Journal of Neuro-Oncology, demonstrates the potential of this technology to complement intraoperative identification of tumor margins without using external markers. A team of researchers affiliated with IDIVAL, the Marqués de Valdecilla University Hospital, and the University of Cantabria has shown that a nanoplasmonic biosensor is capable of distinguishing tumor tissue […]
The General Assembly of the Joint Action PreventNCD (JA PreventNCD) was held in Rome, attended on behalf of the Marqués de Valdecilla Health Research Institute (IDIVAL) and the Health Department of the Government of Cantabria by Ana P. Medina, Blanca Benito, María Zúñiga, and Carlos Fernández Viadero. During the meeting, participants reviewed the project’s progress […]
Documentation for the three funding schemes, together with supporting templates for preparing applications, is now available for consultation. The Spanish Foundation for Science and Technology (FECYT) has launched its 2026 calls for proposals to promote scientific culture and innovation. These calls aim to support initiatives that bring science closer to society, strengthen scientific advice for […]
Cantabria took part in the international ECTOH (European Conference on Tobacco or Health), held in Milan, with the oral presentation “Exposure to second-hand tobacco smoke in households in Cantabria: the influence of minors on indoor smoking behaviours.” The abstract, selected by the conference’s scientific committee for oral communication format, was presented by Ana P. Medina […]
